BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23371454)

  • 21. The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study.
    Wang L; Han S; Yan C; Yang Y; Li Z; Yang Z
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1259-1270. PubMed ID: 33387039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
    Chen C; Chen L; Yao Y; Qin Z; Chen H
    J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas.
    Parker JR; Armstrong DL; Strother D; Rudman DM; Dauser RC; Laurent JP; Deyd J; Rouah PE
    J Child Neurol; 2001 Aug; 16(8):548-52. PubMed ID: 11510923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, radiological, and histological features and treatment outcomes of supratentorial extraventricular ependymoma: 14 cases from a single center.
    Sun S; Wang J; Zhu M; Beejadhursing R; Gao P; Zhang X; Jiao L; Jiang W; Ke C; Shu K
    J Neurosurg; 2018 May; 128(5):1396-1402. PubMed ID: 28686116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.
    Jaing TH; Wang HS; Tsay PK; Tseng CK; Jung SM; Lin KL; Lui TN
    J Neurooncol; 2004 Jul; 68(3):255-61. PubMed ID: 15332330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of copy number variants in the classification of intracranial ependymoma.
    Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
    Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunophenotype of ependymomas.
    Vege KD; Giannini C; Scheithauer BW
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):25-31. PubMed ID: 10937045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supratentorial tanycytic ependymoma.
    Richards AL; Rosenfeld JV; Gonzales MF; Ashley D; Mc Lean C
    J Clin Neurosci; 2004 Nov; 11(8):928-30. PubMed ID: 15519882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.
    Kaneko Y; Takeshita I; Matsushima T; Iwaki T; Tashima T; Fukui M
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):97-103. PubMed ID: 1695040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ependymoma.
    Reni M; Gatta G; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):81-9. PubMed ID: 17482475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic marker analysis in pediatric intracranial ependymomas.
    McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
    J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas].
    Grabenbauer GG; Barta B; Erhardt J; Buchfelder M; Thierauf P; Beck JD; Sauer R
    Strahlenther Onkol; 1992 Dec; 168(12):679-85. PubMed ID: 1481116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.
    Figarella-Branger D; Lepidi H; Poncet C; Gambarelli D; Bianco N; Rougon G; Pellissier JF
    Acta Neuropathol; 1995; 89(3):248-57. PubMed ID: 7754745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and Clinical Significance of Translation Regulatory Long Non-Coding RNA 1 (TRERNA1) in Ependymomas.
    Malgulwar PB; Nambirajan A; Singh M; Suri V; Sarkar C; Sharma MC
    Pathol Oncol Res; 2020 Jul; 26(3):1975-1981. PubMed ID: 31489574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
    Panwalkar P; Clark J; Ramaswamy V; Hawes D; Yang F; Dunham C; Yip S; Hukin J; Sun Y; Schipper MJ; Chavez L; Margol A; Pekmezci M; Chung C; Banda A; Bayliss JM; Curry SJ; Santi M; Rodriguez FJ; Snuderl M; Karajannis MA; Saratsis AM; Horbinski CM; Carret AS; Wilson B; Johnston D; Lafay-Cousin L; Zelcer S; Eisenstat D; Silva M; Scheinemann K; Jabado N; McNeely PD; Kool M; Pfister SM; Taylor MD; Hawkins C; Korshunov A; Judkins AR; Venneti S
    Acta Neuropathol; 2017 Nov; 134(5):705-714. PubMed ID: 28733933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.
    Senetta R; Miracco C; Lanzafame S; Chiusa L; Caltabiano R; Galia A; Stella G; Cassoni P
    Neuro Oncol; 2011 Feb; 13(2):176-83. PubMed ID: 21059755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucin-secreting cellular ependymoma: a light and electron microscopy study.
    Cenacchi G; Morra I; Forni M; Giangaspero F
    Ultrastruct Pathol; 1999; 23(5):319-23. PubMed ID: 10582269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.